Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how the company’s product is worth the investment by protecting products and patients.
News|Articles|December 11, 2015
Single-Use Membrane Filters Offer Fast Flow Rates
Millipore Express PHF hydrophilic, sterilizing-grade filters from EMD Millipore offer faster flow rates to speed the process or reduce the process footprint.
Millipore Express PHF (process protection, high-flux) hydrophilic filters from EMD Millipore, the Life Science division of Merck KGaA, offer efficient and economical buffer filtration. The single-layer, fast-flowing 0.2 µm PES membrane filters provide sterilizing-grade performance and are ideal for buffers, pH adjusters and other process additives and intermediate fluids as well as cleaning fluids. The single-use, gamma-ready filters are available in a fully scalable range of sizes from 25-mm to 30-inch cartridges.
Process efficiency and economy result from broad chemical compatibility, high flow rates, and extended throughput. Offering faster flow rates than most sterilizing-grade filters, Millipore Express filters allow users to accelerate their processes with the same size filter or reduce their process footprint, using a smaller filter. The filters are compatible with a wide range of buffer chemistries including acids and sodium hydroxide across the entire pH range. The filters can withstand multiple steam-in-place or autoclave sterilization cycles.
Source:
Related to this article
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.
Terry Katz, CEO and cofounder of ForgeStop Technology Corporation, explains the company’s CPHI Award-winning connected product technology and how it helps to combat drug counterfeiting.
Bettina Brierley, chief commercial officer at Celtic Renewables, discusses commercialization of biosolvents for pharmaceutical manufacturing.
From AI validation to microstructure imaging, AAPS PharmSci 360 speakers pushed toward faster drug development backed by stronger evidence. Here are PharmTech's biggest takeaways.
Coverage from AAPS PharmSci 360 and CPHI Milan featured discussion about impurities, devices, and supply resilience. This week also included topics such as AI accountability, oral peptides, and new licensing deals.
argenx will acquire Unnatural Products for up to $1.15B, bringing oral macrocyclic peptides and new formulation challenges to its antibody portfolio.
Trending on Pharmaceutical Technology
1
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
2
Our Biggest Takeaways From AAPS PharmSci 360
3
France Remains One of Europe’s Leading Biotech Funding Hubs
4
PharmTech AI Pulse Check: Who's Accountable When a Vendor's AI Model Changes?
5